Synthesis of 2-phenyl- and 2-benzyl derivatives of 4(3Н)-quinazolinone with analgesic activity

Quinazolin-4(3Н)-one derivatives are characterized by a wide range of pharmacological properties, among which the most significant one is a pronounced effect on the central nervous system. In this regard, a molecular design of biologically active compounds that have an analgesic activity due to the formation of ligand-receptor complexes with nociceptive and dopamine receptors, has been performed.

The aim of the study was a molecular design and a subsequent targeted synthesis of 2-phenyl- and 2-benzyl derivatives of 4(3H)-quinazolinone with an analgesic activity, as well as the creation of a mathematical model in order to identify significant molecular descriptors.

Materials and methods. A molecular design was carried out by a logical-structural approach using the PASS program with the identification of the biological activity of the predicted structures, as well as the energy calculation of the ligand-receptor interaction. The synthesis of 2-phenyl derivatives of 4(3H)-quinazolinone was carried out by the reaction of 2-aminobenzamide with aromatic aldehydes in polyphosphoric acid when heated, while the 2-benzyl derivatives were synthesized by fusing amides of anthranilic and homoveratric acids followed by sulfonation with sulfuric acid. The analgesic activity of the synthesized compounds was studied in the models of nociceptive reactions induced by chemical stimuli (a formalin test and “acetic acid writhings”).

Results. A molecular design made it possible to identify promising structures in the series of 4(3H)-quinazolinone derivatives that affect nociceptive and dopamine receptors and have an analgesic activity. A modification was made to the synthesis of 2-phenyl- and 2-benzyl derivatives of 4(3H)-quinazolinone in order to increase the yield of the target products by a simpler and more cost-effective method. The predicted compounds were synthesized by cyclocondensation of anthranilic acid amide with aromatic aldehydes or with homoveraic acid amide. It follows from the primary pharmacological studies results that the synthesized substances are promising from the point of view of creating painkillers based on them. A structure-activity relationship between the molecular descriptors, which are largely responsible for the analgesic activity, and the results of biological tests, has been revealed.

Conclusion. The use of computer modelling made it possible to identify the amino acid residues involved in the formation of the ligand-receptor complex with the nociceptive receptor, and to construct a mathematical model to explain the analgesic activity of 2-phenyl- and 2-benzyl derivatives of 4(3H)-quinazolinone. Modified procedures for the synthesis of target compounds have been proposed. The obtained coefficients of the approximation between the theoretical values and the data of the pharmacological experiment make it possible to state a sufficient reliability of the carried out studies.

1. Amrutkar RD, Ranawat MS. Microwave Assisted Synthesis and Molecular Docking Studies of Some 4-(3H)-quinazolinone Derivatives as Inhibitors of Human Gamma- Aminobutyric Acid Receptor, the GABA (A)R-BETA3 Homopentamer. Med Chem. 2021;17(5):453–61. DOI: 10.2174/1573406416666191216121442

2. Chiriapkin AS, Kodonidi IP, Pozdnyakov DI. Synthesis and evaluation of cerebroprotective activity of novel 6,7-dimethoxyquinazolin-4(3H)-one derivatives containing residues of amino acids and dipeptides. Chimica Techno Acta. 2022;9(2):20229212. DOI: 10.15826/chimtech.2022.9.2.12

3. El-Badry YA, El-Hashash MA, Al-Ali K. Synthesis of bioactive quinazolin-4(3H)-one derivatives via microwave activation tailored by phase-transfer catalysis. Acta Pharm. 2020 Jun 1;70(2):161–178. DOI: 10.2478/acph-2020-0001

4. He J, Wang X, Zhao X, Liang Y, He H, Fu L. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety. Eur J Med Chem. 2012 Aug;54:925–30. DOI: 10.1016/j.ejmech.2012.06.003

5. Haffner CD, Becherer JD, Boros EE, Cadilla R, Carpenter T, Cowan D, Deaton DN, Guo Y, Harrington W, Henke BR, Jeune MR, Kaldor I, Milliken N, Petrov KG, Preugschat F, Schulte C, Shearer BG, Shearer T, Smalley TL Jr, Stewart EL, Stuart JD, Ulrich JC. Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors. J Med Chem. 2015 Apr 23;58(8):3548–71. DOI: 10.1021/jm502009h

6. Sheorey RV, Thangathiruppathy A, Alagarsamy V. Synthesis and pharmacological evaluation of 3-propyl-2-substitutedamino-3h-quinazolin-4-ones as analgesic and anti-inflammatory agents. J Heterocyclic Chem. 2016;53(5):1371–7. DOI: 10.1002/jhet.1973

7. Hrast M, Rožman K, Jukič M, Patin D, Gobec S, Sova M. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3529-3533. DOI: 10.1016/j.bmcl.2017.05.064

8. Obafemi GA, Fadare OA, Jasinski JP, Millikan SP, Obuotor EM, Iwalewa EO, Famuyiwa SO, Sanusi K, Yilmaz Y, Ceylan U. Microwave-assisted synthesis, structural characterization, DFT studies, antibacterial and antioxidant activity of 2-methyl-4-oxo-1,2,3,4-tetrahydroquinazoline-2-carboxylic acid. J Molecul Structur. 2018;1155:610–22. DOI: 10.1016/j.molstruc.2017.11.018

9. Hieu DT, Anh DT, Tuan NM, Hai PT, Huong LT, Kim J, Kang JS, Vu TK, Dung PTP, Han SB, Nam NH, Hoa ND. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents. Bioorg Chem. 2018 Feb;76:258–267. DOI: 10.1016/j.bioorg.2017.12.007

10. El-Badry YA, Anter NA, El-Sheshtawy HS. Synthesis and evaluation of new polysubstituted quinazoline derivatives as potential antimicrobial agents. DetPharmaChemica. 2012;4(3):1361–70.

11. Ma J, Li P, Li X, Shi Q, Wan Z, Hu D, Jin L, Song B. Synthesis and antiviral bioactivity of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives. J Agric Food Chem. 2014 Sep 10;62(36):8928–34. DOI: 10.1021/jf502162y

12. Ovakimyan AG, Bicherov AA, Kodonidi IP, Oganesyan ET, Manvelyan EA, Bicherov AV, Tyurin RV, Zaychenko SB, Manvelyan MM. Prediction, synthesis and study of dophaminergic activity of hydroxy- and methoxyphenyl derivatives of 4-(3)quinazolinone. Modern problems of science and education. 2015;2(Part 2):517. Russian

13. Sarfraz M, Sultana N, Rashid U, Akram MS, Sadiq A, Tariq MI. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases. Bioorg Chem. 2017 Feb;70:237–44. DOI: 10.1016/j.bioorg.2017.01.004

14. Chiriapkin A, Kodonidi I, Pozdnyakov D. Targeted Synthesis and Study of Anti-tyrosinase Activity of 2-Substituted Tetrahydrobenzo[4,5]Thieno[2,3-d]Pyrimidine-4(3H)-One. Iran J Pharm Res. 2022 May 13;21(1):e126557. DOI: 10.5812/ijpr-126557

15. Chiriapkin AS, Kodonidi IP, Pozdnyakov DI, Zolotych DS. Synthesis and QSAR of new azomethine derivatives as agents for the treatment of Alzheimer’s disease. Pharmacologyonline. 2021;3:563–84.

16. Chiriapkin AS, Kodonidi IP, Larsky MV. Targeted Synthesis and Analysis of Biologically Active Azomethine Derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide. Drug development & registration. 2021;10(2):25–31. DOI: 10.33380/2305-2066-2021-10-2-25-31. Russian

17. Chiriapkin AS, Kodonidi IP, Pozdnyakov DI, Glushko AA. Synthesis, in vitro and docking studies of 2-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one derivatives as agents for the treatment of Alzheimer’s disease. Chimica Techno Acta. 2022;9(2):20229204. DOI: 10.15826/chimtech.2022.9.2.04

18. Mansour MA, AboulMagd AM, Abdel-Rahman HM. Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins. RSC Adv. 2020 Sep 15;10(56):34033–34045. DOI: 10.1039/d0ra06424f

19. Dutta T, Chowdhury SK, Ghosh NN, Das M, Chattopadhyay AP, Mandal V. Green synthesis of antimicrobial silver nanoparticles using fruit extract of Glycosmis pentaphylla and its theoretical explanations. Journal of Molecular Structure. 2022;1247:131361. DOI: 10.1016/j.molstruc.2021.131361

20. Ismail EMOA, Shantier SW, Mohammed MS, Musa HH, Osman W, Mothana RA. Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach. Journal of Chemistry. 2021;2021:3613268. DOI: 10.1155/2021/3613268

21. Xing Z, Wu W, Miao Y, Tang Y, Zhou Y, Zheng L, Fu Y, Song Z, Peng Y. Recent advances in quinazolinones as an emerging molecular platform for luminescent materials and bioimaging. Organic Chemistry Frontiers. 2021;8:1867–89. DOI: 10.1039/D0QO01425G

22. Tabrizi L, Yang WS, Chintha C, Morrison L, Samali A, Ramos JW, Erxleben A. Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic Studies. Eur J Inorg Chem. 2021 May 26;2021(20):1921–28. DOI: 10.1002/ejic.202100120

23. Kazemnejadi M, Nasseri MA, Sheikh S, Rezazadeh Z, Alavi Gol SA. Fe3O4@Sap/Cu(II): an efficient magnetically recoverable green nanocatalyst for the preparation of acridine and quinazoline derivatives in aqueous media at room temperature. RSC Adv. 2021 Apr 29;11(26):15989–6003. DOI: 10.1039/d1ra01373d

24. Filimonov DA, Porojkov VV. Forecast of spectra of biological activity of organic compounds. Russ Chem J. 2006;50(2):66–75. Russian

25. Kodonidi IP, Oganesyan ET, Ryabukhin YuI., Smirnova LP, Lysenko TA, Kuleshova SA, Zhoglo EN, Ivashev MN. Synthesis and biological activity of 1,4-dihydro-4-oxopyrimidine n-heterocyclic derivatives. Problem Biological, Medical and Pharmaceutical Chemistry. 2012;(4):19–27. Russian

26. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987 Jul;30(1):103–14. DOI:10.1016/0304-3959(87)90088-1

27. Berestovitskaya VM, Vasil’eva1 OS, Ostroglyadov ES, Aleksandrova SM, Tyurenkov IN, Merkushenkova OV, Bagmetova VV. Synthesis and neuropsychotropic activity of indole-containing derivatives of gamma-aminobutyric acid. Khimiko-Farmatsevticheskii Zhurnal. 2018;52(5):10–4. DOI: 10.30906/0023-1134-2018-52-5-10-14

28. Galenko-Jaroshevskij AP, Anisimova VA, Minkin VI, Tolpygin IE, Varlashkina IA, Futorjanskaja TN, Podtynnykh EV, Alferova GA. Agent possessing topical anesthetic effect. Russian Federation Patent RUS 2313341 C1. 2007 Dec 27. Russian

29. Connolly DJ, Cusack D, O’Sullivan TP, Guiry PJ. Synthesis of quinazolinones and quinazolines. Tetrahedron. 2005;61:10153–202. DOI: 10.1002/CHIN.200603235

30. Martin TM, Harten P, Venkatapathy R, Das S, Young DM. A hierarchical clustering methodology for the estimation of toxicity. Toxicol Mech Methods. 2008;18(2–3):251–66. DOI: 10.1080/15376510701857353

31. Manvelyan MM, Prizova EYu, Semionova IA, Shevtsova YuA, Stonogina TA, Manvelyan EA. Influence of quinazolinone-4 derivatives on a blood coagulability. Materials of the I Scientific and Practical Conference with International Participation “The Exclusion of Various Genesis and Ways of its Pharmacological Correction” (2–3 Nov 2015, Pyatigorsk). Pharmacy & Pharmacology. 2015;3(5s):1–128. DOI: 10.19163/2307-9266-2015-3-5s-1-128. Russian

32. Melnikov F, Kostal J, Voutchkova-Kostal A, Zimmerman JB, Anastas PT. Assessment of predictive models for estimating the acute aquatic toxicity of organic chemicals. Green Chem. 2016;18:4432–45. DOI: 10.1039/C6GC00720A.

33. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525–30. DOI: 10.1073/pnas.0705924104

34. Yao K, Dou B, Zhang Y, Chen Z, Li Y, Fan Z, Ma Y, Du S, Wang J, Xu Z, Liu Y, Lin X, Wang S, Guo Y. Inflammation-the role of TRPA1 channel. Front Physiol. 2023 Feb 16;14:1093925. DOI: 10.3389/fphys.2023.1093925

35. Li J, Zhang H, Du Q, Gu J, Wu J, Liu Q, Li Z, Zhang T, Xu J, Xie R. Research Progress on TRPA1 in Diseases. J Membr Biol. 2023 Apr 11. DOI: 10.1007/s00232-023-00277-x

36. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007 Jan;87(1):165–217. DOI: 10.1152/physrev.00021.2006

37. Hunskaar S, Berge OG, Hole K. Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain. 1986 Apr;25(1):125–32. DOI:10.1016/0304-3959(86)90014-X

38. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992 Oct;51(1):5–17. DOI: 10.1016/0304-3959(92)90003-T

39. Katunina EA, Titova NV, Bezdol’nyĭ IuN, Shykkerimov RK, Gasanov MG, Burd SG, Lebedeva AV, Boĭko AN. Dopamine receptor agonists: new forms and new possibilities in the treatment of Parkinson’s disease // Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(5):34–40. DOI: 10.17116/jnevro20151155134-40. Russian

40. Kolotilova OI, Korenyuk II, Khusainov DR, Cheretaev IV. Dopaminergic system of the brain. The Bryansk State University Herald. 2014;(4):97–106. Russian